Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1992-2-6
|
pubmed:abstractText |
In order to study the effects of insulin-like growth factor (IGF-I) and insulin-like growth factor binding protein (IGFBP-1) on human granulosa cell proliferation after in vitro fertilization, cells were obtained after oocyte retrieval and cultured in the presence or absence of graded amounts of recombinant IGF-I, purified IGFBP-1 and [3H]thymidine. Physiological concentrations of IGF-I (2-200 ng/ml) were found to stimulate [3H]thymidine incorporation into the cells in a concentration-dependent manner. Half-maximal stimulation of [3H]thymidine incorporation was obtained with 10 ng/ml exogenous IGF-I, which was chosen for suppression experiments with graded amounts of purified IGFBP-1. Suppression of IGF-stimulated thymidine incorporation was observed when 200 ng/ml or more of IGFBP-1 was added to the culture medium. The same concentration of IGFBP-1 also markedly inhibited binding of [125I]iodotyrosyl IGF-I to the cells. It is concluded that: (i) after a refractory period, granulosa cells from hyperstimulated follicles retained their mitogenic activity; (ii) IGF-I is capable of stimulating DNA amplification in granulosa cells; and (iii) IGFBP-1 inhibits the IGF-I stimulated proliferation in these cells. In view of our previous studies showing that IGFBP-1 is synthesized by the granulosa cells as they luteinize, the present results suggest that IGFBP-1 is one of the endogenous factors locally regulating the growth and differentiation of granulosa cells.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Carrier Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor Binding...,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor I,
http://linkedlifedata.com/resource/pubmed/chemical/Iodine Radioisotopes
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0268-1161
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
770-3
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1721920-Carrier Proteins,
pubmed-meshheading:1721920-Cells, Cultured,
pubmed-meshheading:1721920-Corpus Luteum,
pubmed-meshheading:1721920-Female,
pubmed-meshheading:1721920-Gene Amplification,
pubmed-meshheading:1721920-Granulosa Cells,
pubmed-meshheading:1721920-Humans,
pubmed-meshheading:1721920-Immunoblotting,
pubmed-meshheading:1721920-Insulin-Like Growth Factor Binding Proteins,
pubmed-meshheading:1721920-Insulin-Like Growth Factor I,
pubmed-meshheading:1721920-Iodine Radioisotopes,
pubmed-meshheading:1721920-Radioligand Assay
|
pubmed:year |
1991
|
pubmed:articleTitle |
Insulin-like growth factor binding protein-1 inhibits the DNA amplification induced by insulin-like growth factor I in human granulosa-luteal cells.
|
pubmed:affiliation |
Department I of Obstetrics and Gynecology, Helsinki University Central Hospital, Finland.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|